Avalo Therapeutics' AVTX-009 advances in a Phase 2 trial for hidradenitis suppurativa with promising efficacy. Read why I rate AVTX stock a Speculative Buy.
Avalo Therapeutics: Speculative Buy Ahead Of AVTX-009’s LOTUS Results (NASDAQ:AVTX)
Seeking Alpha Stock1 hrs ago
1
The Motley Fool
Reuters US Economy
Reuters US Business
Essentiallysports Basketball
Raw Story